safety and efficacy of obe-cel in r/r adult b-all: results of the pivotal felix study
Published 1 year ago • 261 plays • Length 4:45Download video MP4
Download video MP3
Similar videos
-
1:26
obe-cel for r/r b-all: pooled analysis of the ongoing felix study
-
2:41
safety and efficacy of actaly-cel™ in r/r pediatric b-all
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
1:57
investigating the efficacy and safety of adct-602 in patients with r/r b-all
-
1:58
comparing the safety & efficacy of reversible and irreversible btk inhibitors in cll
-
0:59
the safety and efficacy of etavopivat in scd
-
1:48
the potential of bispecific antibody-containing combinations in patients with b-cell lymphomas
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
1:12
the safety and efficacy of mb-106 for the treatment of waldenström’s macroglobulinemia
-
1:19
safety and efficacy of mb-106 for the treatment of r/r fl
-
1:47
real-world outcomes of tandem transplantation in patients with newly diagnosed multiple myeloma
-
0:45
difference between quality of life & patient-reported outcomes
-
0:46
simplify studies: analysis of the meaningful symptomatic change in patients with myelofibrosis
-
1:06
epcore nhl-1: two and a half year follow-up of epcoritamab in dlbcl
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
7:54
felix study shows obe-cel has tolerable immunotoxicity profile
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
2:41
an overview of the latest advances in hematology
-
1:50
an overview of the promising upcoming therapies for patients with lr-mds